OT Breast Cancer
Videos

Exciting Developments

Megan Kruse, MD, department of Hematology and Medical Oncology, Cleveland Clinic, is encouraged by today’s new breast cancer treatment options.

Management of Symptoms

Megan Kruse, MD, department of Hematology and Medical Oncology, Cleveland Clinic, identifies a few unmet needs in the breast cancer community.

Breast Cancer Breakthroughs

George W. Sledge, Jr., MD, professor of Medicine and chief, Division of Oncology, Stanford University, shares his thoughts on the most recent and significant breakthroughs.

‘Less is Frequently More’

George W. Sledge, Jr., MD, professor of Medicine and chief, Division of Oncology, Stanford University, summarizes the TAILORx trial.

Alternative Therapy Options

Not all breast cancer patients require chemotherapy. Megan Kruse, MD, department of Hematology and Medical Oncology, Cleveland Clinic, explains.

A Close Eye on Clinical Trials

Megan Kruse, MD, department of Hematology and Medical Oncology, Cleveland Clinic, shares her interest in a series of clinical trials looking at the use of CDK4/6 inhibitors for patients with metastatic HER2+ breast cancer.

A Better Understanding

How an improved understanding of biology has led to dramatic improvements in the treatment of breast cancer is explained by George W. Sledge, Jr., MD, professor of Medicine and chief, Division of Oncology, Stanford University.

Tumor Behaviors and Biology

When it comes to determining the best treatment for breast cancer patients, it’s not just about the tumor size or lymph nodes any longer.

Debunking Myths

George W. Sledge, Jr., MD, professor of Medicine and chief, Division of Oncology, Stanford University, reveals the biggest myths regarding breast cancer and how they can be overcome.

Medical Needs

George W. Sledge, Jr., MD, professor of Medicine and chief, Division of Oncology, Stanford University, identifies two unmet needs in breast cancer.
Loading